Cochi SL, Fleming DW, Hull HF, Preblud SR, Orenstein WA (December 1986). "Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine". American Journal of Diseases of Children. 140 (12): 1226–1230. doi:10.1001/archpedi.1986.02140260028019. PMID3490784.
Weinberg GA, Granoff DM (October 1988). "Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease". The Journal of Pediatrics. 113 (4): 621–631. doi:10.1016/S0022-3476(88)80369-X. PMID3050001.
Cox AD, Kuo Lee R, Ulanova M, Bruce MG, Tsang RS (January 2021). "Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019". Vaccine. 39 (4): 627–632. doi:10.1016/j.vaccine.2020.12.015. PMID33358264. S2CID229695991.
Broome CV (August 1987). "Epidemiology of Haemophilus influenzae type b infections in the United States". The Pediatric Infectious Disease Journal. 6 (8): 779–782. doi:10.1097/00006454-198708000-00036. PMID3313240.
Osterholm MT, Rambeck JH, White KE, Jacobs JL, Pierson LM, Neaton JD, et al. (September 1988). "Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota". JAMA. 260 (10): 1423–1428. doi:10.1001/jama.1988.03410100113035. PMID3261350.
Granoff DM, Shackelford PG, Suarez BK, Nahm MH, Cates KL, Murphy TV, et al. (December 1986). "Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine". The New England Journal of Medicine. 315 (25): 1584–1590. doi:10.1056/NEJM198612183152505. PMID3491315.
Robbins JB, Schneerson R, Anderson P, Smith DH (October 1996). "The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines". JAMA. 276 (14): 1181–1185. doi:10.1001/jama.276.14.1181. PMID8827975.
Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, et al. (January 1993). "Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination". JAMA. 269 (2): 246–248. doi:10.1001/jama.1993.03500020080036. PMID8417244.
Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM (April 1993). "Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine". The Journal of Pediatrics. 122 (4): 517–523. doi:10.1016/s0022-3476(05)83529-2. PMID8463894.
Einhorn MS, Weinberg GA, Anderson EL, Granoff PD, Granoff DM (August 1986). "Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein". Lancet. 2 (8502): 299–302. doi:10.1016/s0140-6736(86)90001-2. PMID2874327.
Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, et al. (August 1992). "Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants". The Journal of Pediatrics. 121 (2): 187–194. doi:10.1016/s0022-3476(05)81186-2. PMID1640282.
Bar-On ES, Goldberg E, Hellmann S, Leibovici L (April 2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". The Cochrane Database of Systematic Reviews (4): CD005530. doi:10.1002/14651858.CD005530.pub3. PMID22513932.
World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Cochi SL, Fleming DW, Hull HF, Preblud SR, Orenstein WA (December 1986). "Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine". American Journal of Diseases of Children. 140 (12): 1226–1230. doi:10.1001/archpedi.1986.02140260028019. PMID3490784.
Weinberg GA, Granoff DM (October 1988). "Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease". The Journal of Pediatrics. 113 (4): 621–631. doi:10.1016/S0022-3476(88)80369-X. PMID3050001.
Cox AD, Kuo Lee R, Ulanova M, Bruce MG, Tsang RS (January 2021). "Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019". Vaccine. 39 (4): 627–632. doi:10.1016/j.vaccine.2020.12.015. PMID33358264. S2CID229695991.
Broome CV (August 1987). "Epidemiology of Haemophilus influenzae type b infections in the United States". The Pediatric Infectious Disease Journal. 6 (8): 779–782. doi:10.1097/00006454-198708000-00036. PMID3313240.
Osterholm MT, Rambeck JH, White KE, Jacobs JL, Pierson LM, Neaton JD, et al. (September 1988). "Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota". JAMA. 260 (10): 1423–1428. doi:10.1001/jama.1988.03410100113035. PMID3261350.
Granoff DM, Shackelford PG, Suarez BK, Nahm MH, Cates KL, Murphy TV, et al. (December 1986). "Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine". The New England Journal of Medicine. 315 (25): 1584–1590. doi:10.1056/NEJM198612183152505. PMID3491315.
Robbins JB, Schneerson R, Anderson P, Smith DH (October 1996). "The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines". JAMA. 276 (14): 1181–1185. doi:10.1001/jama.276.14.1181. PMID8827975.
Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, et al. (January 1993). "Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination". JAMA. 269 (2): 246–248. doi:10.1001/jama.1993.03500020080036. PMID8417244.
Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM (April 1993). "Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine". The Journal of Pediatrics. 122 (4): 517–523. doi:10.1016/s0022-3476(05)83529-2. PMID8463894.
Einhorn MS, Weinberg GA, Anderson EL, Granoff PD, Granoff DM (August 1986). "Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein". Lancet. 2 (8502): 299–302. doi:10.1016/s0140-6736(86)90001-2. PMID2874327.
Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, et al. (August 1992). "Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants". The Journal of Pediatrics. 121 (2): 187–194. doi:10.1016/s0022-3476(05)81186-2. PMID1640282.
Bar-On ES, Goldberg E, Hellmann S, Leibovici L (April 2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". The Cochrane Database of Systematic Reviews (4): CD005530. doi:10.1002/14651858.CD005530.pub3. PMID22513932.
Cox AD, Kuo Lee R, Ulanova M, Bruce MG, Tsang RS (January 2021). "Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019". Vaccine. 39 (4): 627–632. doi:10.1016/j.vaccine.2020.12.015. PMID33358264. S2CID229695991.